PLEASANTON, Calif., Feb. 1, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has provided 510(k) clearance to the cobas® CT/NG Test for the detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections in ... read more

Roche (SIX: RO, ROG; OTCQX: RHHBY), a leader in research-focused healthcare with combined strengths in pharmaceuticals, life science tools and diagnostics, announced today that it has commenced a ... read more

Roche (SIX: RO, ROG; OTCQX: RHHBY) today responded to an announcement from Illumina, Inc. (NASDAQ: ILMN) that its Board of Directors has adopted a shareholder rights plan. ... read more

We kindly invite investors and analysts to participate in a conference call that will be held on Wednesday, 25 January at 7:00 am ET / 1:00 pm CET. ... read more

NUTLEY, N.J., Nov. 7, 2011 /PRNewswire/ -- Roche announced today that Pamela Carroll, PhD, has joined the company as Nutley Oncology Discovery Site Head and Global Head, Pathways Biology within Pharma Research and Early Development (pRED). Pam joins Roche from Belfer Institute of Applied Cancer Sciences at Dana Farber Cancer ... read more

NUTLEY, N.J., Oct. 17, 2011 /PRNewswire/ -- Roche is pleased to announce the appointment of Hyam Levitsky, MD, as Head of Cancer Immunology Experimental Medicine, effective September 1. Levitsky joined Roche from The Johns Hopkins University School of Medicine, where he has been Professor of Oncology, Medicine and Urology and ... read more

NUTLEY, N.J., Oct. 10, 2011 /PRNewswire/ -- Today, Roche announced that Harsukh Parmar, MD, has joined the company as the new Head of Translational and Experimental Medicine (TM) for the Inflammation Discovery and Translational Area (DTA). In this role, Harsukh will drive the strategy and implementation of early clinical development ... read more

NUTLEY, N.J., Oct. 3, 2011 /PRNewswire/ -- For the second year, Roche, in partnership with the North Jersey Regional Chamber of Commerce/Clifton Economic Development Assistance Commission (CEDAC) and the Nutley Chamber of Commerce (NCoC), is hosting its local community initiative, "Roche Goes to Town," in Nutley and Clifton, New Jersey. ... read more

NUTLEY, N.J., Sept. 30, 2011 /PRNewswire/ -- Roche announced today the opening of a new state-of-the-art clinical supply manufacturing facility on its campus in Nutley, N.J. The Roche Center of Excellence produces dosage forms of highly potent compounds for preclinical safety studies, and Phase 1 and 2 clinical studies. The ... read more

BASEL, Switzerland, Sept. 14, 2011 /PRNewswire/ -- Roche announced today that Rainer Metternich, PhD, has been named Head of Small Molecules Research (SMR), effective immediately. He takes over from Klaus Strein, who will retire from Roche. SMR is a key part of Roche's Pharma Research and Early Development (pRED) organization. As ... read more

BASEL, Switzerland and NUTLEY, N.J., Sept. 9, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the initiation of its first Phase 1 clinical trial to investigate the safety and tolerability of a molecule designed to address the cognitive and behavioral deficits associated with Down syndrome. "There is ... read more

In May 2011, The University of Iowa, Roy J. Carver Center for Genomics (CCG), entered into an agreement with Roche NimbleGen to provide microarray services through the Roche ... read more

Medicinal Genomics, a private company headquartered in Marblehead, Mass., USA and the Netherlands, announced today that it has sequenced the entire genomes of Cannabis sativa and Cannabis indica, ... read more

Roche (SIX: RO, ROG; OTCQX: RHHBY) and PerkinElmer (NYSE: PKI) today announced a new supply agreement for distribution of the NimbleGen CGX microarray ... read more